Home

Armistice Capital Master Fund Ltd.

CIK 1633584 · last filed 2022-02-28

Armistice Capital Master Fund Ltd. is a corporate insider who has filed 74 SEC Form 4 insider transactions across 12 companies since 2017. The most recent filing shows the insider bought $335.4K of AVTX on Feb 28, 2022. Across all open-market trades the lifetime net is −$1.01B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $90.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$90.80M

Companies

12

Total Filings

74

Lifetime Open-Market Net

-$1.01B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director 16,393 $18.82 $308.5K $335.4K 1 2022-02-28
Avalo Therapeutics, Inc. (CERC) Delisted Director 39,712,442 $2.93 $116.36M $24.90M 19 2021-08-18
EYEG Director 2,576,500 $34.75 $89.54M -$39.51M 5 2021-08-03
AYTU Director 134,238 $2.18 $292.6K -$121.50M 8 2021-05-10
TENX Director 2,449 $15.72 $38.5K $369.7K 1 2020-09-03
Vaxart, Inc. (VXRT) Delisted Director 14,970,909 $0.32 $4.79M -$898.30M 5 2020-06-30
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted 10%+ Owner 4,400,000 — — $2.60M 1 2020-01-28
ACHV 10%+ Owner 95,599 $6.50 $621.4K -$2.37M 1 2019-06-13
Del Frisco's Restaurant Group, Inc. (DFRG) Delisted 10%+ Owner 6,000,000 — — $12.02M 4 2019-04-30
Valeritas Holdings Inc. (VLRX) Delisted 10%+ Owner 1,972,500 — — $845.8K 3 2018-12-20
Avalo Therapeutics, Inc. (CERCW) Delisted 10%+ Owner 35,025,915 — — $3.38M 13 2018-10-09
Fresh Tracks Therapeutics, Inc. (VICL) Delisted 10%+ Owner 1,222,757 — — $7.58M 4 2018-07-02

Recent Filings

74 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-02-28 AVTX Buy (P) +420,000 $335.4K EDGAR
2021-08-18 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +150,000 $414.6K EDGAR
2021-08-03 EYEG Sell (S) −782,889 -$1.94M EDGAR
2021-07-29 EYEG Mixed −6,901,914 -$31.36M EDGAR
2021-05-18 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +540,000 $1.18M EDGAR
2021-05-10 AYTU Other (J) +27,132 $0 EDGAR
2020-12-07 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +60,000 $146.4K EDGAR
2020-11-25 Avalo Therapeutics, Inc. (CERC) Delisted Buy (P) +300,000 $710.6K EDGAR
2020-11-12 — Buy (P) +7,200 $25.8K
2020-10-01 — Sell (S) −31,500 -$4.2K
Showing 1–10 of 74
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.